The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine ...
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
O n March 14, Dr. Mehmet Oz will answer questions from members of the Senate Finance Committee in his confirmation hearing to ...
ET Now on MSN16h
Who is Gauri Spratt? Aamir Khan’s new partner and entrepreneur with a fascinating backgroundAamir Khan, who has always been known for his privacy, shared the heartwarming news with the media, admitting that he and ...
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...
Meanwhile, an open-label trial enrolled patients on background antiretroviral (bART) therapy. Both studies met the primary efficacy endpoint of non-inferiority to comparator antiretroviral therapies ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback